SenesTech (NASDAQ:SNES) Coverage Initiated at StockNews.com

StockNews.com initiated coverage on shares of SenesTech (NASDAQ:SNES) in a report issued on Monday. The brokerage issued a sell rating on the stock.

Separately, HC Wainwright lifted their price target on shares of SenesTech from $3.50 to $10.00 and gave the company a “buy” rating in a research note on Thursday, December 12th.

SenesTech Stock Performance

Shares of SenesTech stock opened at $2.13 on Monday. The stock’s fifty day simple moving average is $2.95 and its 200 day simple moving average is $2.82. The company has a current ratio of 6.32, a quick ratio of 4.92 and a debt-to-equity ratio of 0.05. The company has a market capitalization of $2.20 million, a PE ratio of -0.21 and a beta of 0.09. SenesTech has a 12 month low of $1.90 and a 12 month high of $9.80.

SenesTech (NASDAQ:SNES) last released its quarterly earnings results on Wednesday, March 12th. The company reported ($1.22) EPS for the quarter, topping analysts’ consensus estimates of ($1.50) by $0.28. SenesTech had a negative return on equity of 150.33% and a negative net margin of 403.51%. The company had revenue of $0.50 million for the quarter, compared to analyst estimates of $0.71 million. On average, research analysts predict that SenesTech will post -10.22 EPS for the current year.

SenesTech Company Profile

SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.